TECH (Bio-Techne) Insider Ownership: 1.97 % (As of Aug. 04, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TECH Bio-Techne Corp TECH
88 GF Score
Price $72.14
GF Value $72.79
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Bio-Techne Insider Ownership?

Bio-Techne TECH +0.06% 88 Insider Ownership is 1.97 % as of Aug. 04, 2026. GuruFocus rates TECH with a GF Score™ of 88/100 and a GF Value™ of $72.79 (Fairly Valued). The stock has 8 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bio-Techne's insider ownership is 1.97%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bio-Techne's Institutional Ownership is 112.72%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bio-Techne's Float Percentage Of Total Shares Outstanding is 87.62%.

Bio-Techne Insider Ownership Historical Data

* Premium members only.

The historical data trend for Bio-Techne's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Techne Insider Ownership Chart

Bio-Techne Historical Data

The historical data trend for Bio-Techne can be seen below:

2025-06-30 2025-07-31 2025-08-31 2025-09-30 2025-10-31 2025-11-30 2026-01-31 2026-02-28 2026-05-31 2026-06-30
Insider Ownership 1.89 1.91 1.93 1.93 1.93 1.95 1.95 1.94 1.96 1.97
TECH
88GF Score
Bio-Techne Corp TECH
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Techne Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 1.97 % mean?
Bio-Techne (TECH) has a Insider Ownership of 1.97 % as of Aug. 04, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Bio-Techne and its competitors.
Is Bio-Techne's Insider Ownership too high?
Bio-Techne's current Insider Ownership is 1.97 %. Overall, Bio-Techne has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's Insider Ownership compare to CYTK and SMMT?
Bio-Techne's Insider Ownership of 1.97 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Bio-Techne and its competitors. Bio-Techne's current Insider Ownership is 1.97 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Based on GuruFocus' analysis, Bio-Techne (TECH) is currently considered Fairly Valued. The stock's GF Value™ is $72.79, compared to a current price of $72.14 — trading 0.9% below its estimated fair value. The current Insider Ownership is 1.97 %. Bio-Techne's overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Bio-Techne (TECH), the current Insider Ownership is 1.97 % as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Techne (TECH) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued. The current stock price of $72.14 is trading 0.9% below its estimated GF Value™ of $72.79. GuruFocus considers Bio-Techne to be Fairly Valued.

Key valuation signals for TECH:

  • Insider Ownership: 1.97 %
  • GF Value™: $72.79 vs. price of $72.14 (0.9% below fair value)
  • GF Score™: 88/100 with 8 warning signs

No single metric tells the full story. See the TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio-Techne Business Description

Other Exchanges TE1:GermanyT1CH34:Brazil
Address 614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
88GF Score

Get the complete analysis for TECH

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$72.14
Price
$72.79
GF Value